Oncology Venture ApS-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Oncology Venture ApS - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014277
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:デンマーク
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Oncology Venture ApS (Oncology Venture), a subsidiary of Oncology Venture Sweden AB is a drug development company that discovers new oncology products, and rescuing failed ones. The company provides gene-tumor-technology for identifying patients with resistance to anticancer drug. Its activities include in-licensing drugs with low response rate performing phase II trials on a selected population and identifying the ones that are positive for its proprietary biomarker; and out-licensing the drugs with high response rate. Oncology Venture conducts research and development to discover new drugs. The company partners with other pharmaceutical companies to co-develop oncology drugs. Oncology Venture is headquartered in Hoersholm, Denmark.

Oncology Venture ApS – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Oncology Venture ApS, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Oncology Venture ApS, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Oncology Venture ApS, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Oncology Venture ApS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Oncology Venture ApS, Medical Devices Deals, 2011 to YTD 2017 9
Oncology Venture ApS, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Oncology Venture ApS, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Oncology Venture Raises USD0.56 Million in Venture Financing 11
Licensing Agreements 12
Oncology Venture Enters into Licensing Agreement with Lantern Pharma 12
Oncology Venture Enters into Licensing Agreement with Medical Prognosis Institute 13
TopoTarget Enters Into Licensing Agreement With Oncology Venture For APO010 14
Equity Offering 15
Oncology Venture Raises USD1 Million in Private Placement of Shares 15
Oncology Venture ApS – Key Competitors 16
Oncology Venture ApS – Key Employees 17
Oncology Venture ApS – Locations And Subsidiaries 18
Head Office 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Oncology Venture ApS, Pharmaceuticals & Healthcare, Key Facts 2
Oncology Venture ApS, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Oncology Venture ApS, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Oncology Venture ApS, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Oncology Venture ApS, Deals By Therapy Area, 2011 to YTD 2017 8
Oncology Venture ApS, Medical Devices Deals, 2011 to YTD 2017 9
Oncology Venture ApS, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Oncology Venture Raises USD0.56 Million in Venture Financing 11
Oncology Venture Enters into Licensing Agreement with Lantern Pharma 12
Oncology Venture Enters into Licensing Agreement with Medical Prognosis Institute 13
TopoTarget Enters Into Licensing Agreement With Oncology Venture For APO010 14
Oncology Venture Raises USD1 Million in Private Placement of Shares 15
Oncology Venture ApS, Key Competitors 16
Oncology Venture ApS, Key Employees 17

★海外企業調査レポート[Oncology Venture ApS-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Pristine Sun LLC:電力:M&Aディール及び事業提携情報
    Summary Pristine Sun LLC (Pristine Sun) is a renewable energy company that develops small utility-scale solar PV power plants. The company offers consulting, and project financing and funding services. Its consulting services include solar project development, operation and maintenance, EPC and inst …
  • WEG SA:企業の戦略・SWOT・財務情報
    WEG SA - Strategy, SWOT and Corporate Finance Report Summary WEG SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, prov …
  • CRH Medical Corp (CRH):企業の財務・戦略的SWOT分析
    Summary CRH Medical Corp (CRH Medical), is a medical device company that offers treatment of hemorrhoids. The company provides CRH O’Regan System, a hemorrhoid technology for treating hemorrhoid. It offers topical ointments and creams including preparation H for the treatment of hemorrhoid. CRH Medi …
  • Sagent Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Sagent Pharmaceuticals Inc (Sagent), formerly Sagent Holding Co, a subsidiary of Nichi-Iko Pharmaceutical Co Ltd, is a biopharmaceutical company that develops and manufactures injectable products. The company offers products such as amikacin sulfate injection, USP, ampicillin and sulbactam f …
  • DURECT Corp (DRRX)-製薬・医療分野:企業M&A・提携分析
    Summary DURECT Corp (Durect) is a specialty pharmaceutical company. It carries out the development of pharmaceutical systems based on its proprietary drug delivery technology platforms to treat chronic debilitating diseases. It also undertakes the development of biotechnology products. The company’s …
  • Slavneft-Megionneftegaz (MFGS):企業の財務・戦略的SWOT分析
    Summary Slavneft-Megionneftegaz (Megionneftegaz), a subsidiary of Slavneft, is an oil and gas company that operates oil fields. The company’s activities include appraisal of oil and gas fields, oil and gas production, and well drilling and operation. Megionneftegaz develops and introduces advanced t …
  • New Hope Corp Ltd:企業の戦略・SWOT・財務情報
    New Hope Corp Ltd - Strategy, SWOT and Corporate Finance Report Summary New Hope Corp Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Nihon Chouzai Co Ltd (3341):企業の財務・戦略的SWOT分析
    Nihon Chouzai Co Ltd (3341) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • The Midcounties Co-operative:企業の戦略・SWOT・財務情報
    The Midcounties Co-operative - Strategy, SWOT and Corporate Finance Report Summary The Midcounties Co-operative - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Mayne Pharma Group Ltd (MYX)-製薬・医療分野:企業M&A・提携分析
    Summary Mayne Pharma Group Ltd (Mayne Pharma), formerly Mayne Pharma International Pty Ltd, a subsidiary of Hospira Inc, is a specialty pharmaceutical company that manufactures and markets branded and generic medicinal products. The company’s products comprise astrix capsules and tablets, erymax cap …
  • Verbundnetz Gas Aktiengesellschaft:石油・ガス:M&Aディール及び事業提携情報
    Summary Verbundnetz Gas AG (VNG), a subsidiary of EnBW Energie Baden-Wurttemberg AG, is a natural gas company that explores, produces, stores, trades and transports natural gas. The company has natural gas licenses on the Norwegian continental shelf and the Danish North Sea. VNG also offers gas stor …
  • Entreprise Tunisienne d’Activites Petrolieres:企業の戦略的SWOT分析
    Entreprise Tunisienne d'Activites Petrolieres - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors …
  • ChargePoint Inc:電力:M&Aディール及び事業提携情報
    Summary ChargePoint Inc (ChargePoint), formerly Coulomb Technologies Inc, is a charging network company that designs, builds and supports electric vehicle charging services. The company provides charging stations for electric vehicles. It designs, builds, and supports charging stations of different …
  • PepVax Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary PepVax Inc (PepVax) is a biotechnology company that develops novel therapeutics for the treatment of cancer. The company provides pipeline product candidate portfolio such as HCA587, which is being developing to treat hepatocellular carcinoma and TFDP3, a drug candidate which is being used f …
  • Osaka Gas Co Ltd (9532):企業の財務・戦略的SWOT分析
    Osaka Gas Co Ltd (9532) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Harvard Pilgrim Health Care Inc:企業の戦略・SWOT・財務情報
    Harvard Pilgrim Health Care Inc - Strategy, SWOT and Corporate Finance Report Summary Harvard Pilgrim Health Care Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Sui Northern Gas Pipelines Ltd (SNGP):企業の財務・戦略的SWOT分析
    Sui Northern Gas Pipelines Ltd (SNGP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Luxoft Holding Inc:企業の戦略・SWOT・財務情報
    Luxoft Holding Inc - Strategy, SWOT and Corporate Finance Report Summary Luxoft Holding Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Rocky Mountain Chocolate Factory, Inc.:企業の戦略・SWOT・財務分析
    Rocky Mountain Chocolate Factory, Inc. - Strategy, SWOT and Corporate Finance Report Summary Rocky Mountain Chocolate Factory, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT ana …
  • Checkpoint Surgical Inc:医療機器:M&Aディール及び事業提携情報
    Summary Checkpoint Surgical Inc (Checkpoint Surgical) is a medical device company that offers neuro-protective surgical devices. The company’s products include checkpoint stimulators and locators; and checkpoint head and neck systems. Its checkpoint stimulators and locators provide biphasic stimulat …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆